Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0029463 (osteosarcoma)
 16,637 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The nude mouse bearing a human tumor heterotransplant is a useful model for studying the tumor localization of radiolabeled compounds. The biological tissue distribution of carbon 14-labeled alpha-aminoisobutyric acid (AIB), a synthetic, nonmetabolized amino acid, was determined in nude mice bearing human malignant melanoma heterotransplants in order to investigate the feasibility of using carbon 11 (t 1/2, 20.4 min)-labeled AIB for the visualization of human melanoma in vivo with positron emission tomography (PET). Our laboratory has previously demonstrated the use of 11C-labeled AIB as a tumor-imaging agent in a number of animal tumor models. The mean relative concentration of 14C-labeled AIB in tumor tissue at 45 min was 1.95 in this melanoma model. Tumor/blood and tumor/muscle ratios at 45 min postinjection were 5.42 and 12.2, respectively. These values suggest that 11C-labeled AIB may be useful for the in vivo study of malignant melanoma in humans. Alpha-aminoisobutyric acid (AIB), a synthetic, nonmetabolized amino acid, is thought to be actively accumulated into viable cells primarily by the A-type, or "alanine-prefering", amino acid transport system. AIB has been labeled with the short-lived, positron-emitting radionuclide, carbon 11 (t 1/2, 20.4 min), using a modified Bucherer-Strecker synthesis for amino acids. 11C-labeled AIB has been used to visualize tumors in dogs bearing spontaneous cancers, such as adenocarcinoma, lymphosarcoma, and osteogenic sarcoma, by utilizing positron-emission tomography (PET) and high-energy gamma (HEG) scintigraphy at the Sloan-Kettering Institute.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants. 397 9

Alpha-aminoisobutyric acid (AIB), or alpha-methyl alanine, is a nonmetabolized amino acid transported into cells, particularly malignant cells, predominantly by the 'A' amino acid transport system. Since it is not metabolized, [1-11C]-AIB can be used to quantify A-type amino acid transport into cells using a relatively simple compartmental model and quantitative imaging procedures (e.g. positron tomography). The tissue distribution of [1-11C]-AIB was determined in six dogs bearing spontaneous tumors, including lymphosarcoma, osteogenic sarcoma, mammary carcinoma, and adenocarcinoma. Quantitative imaging with tissue radioassay confirmation at necropsy showed poor to excellent tumor localization. However, in all cases the concentrations achieved appear adequate for amino acid transport measurement at known tumor locations. The observed low normal brain (due to blood-brain barrier exclusion) and high (relative to brain) tumor concentrations of [1-11C]-AIB suggest that this agent may prove effective for the early detection of human brain tumors.
 ...
PMID:Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies. 397 10

A retrospective review of 112 cases treated by one author (J.C.) over the 21 year period 1953-1973 is performed. In 62% of the cases squamous cell carcinoma was the histologic diagnosis, with adenoid cystic carcinoma accounting for a further 16%. The remaining histologic types were few in number and included fibrosarcoma, muco-epidermoid carcinoma, melanoma, chondrosarcoma, adenocarcinoma, malignant Schwannoma, lymphosarcoma, malignant mixed tumor, rhabdomyosarcoma, angiosarcoma, and osteogenic sarcoma. Three years following diagnosis more than 1/3 of the squamous cell carcinomas were alive but by 10 years the survival rate had fallen to 16%. Orbital involvement at the time of presentation or noted at surgery had a poor prognosis with a 17% five year cure rate and only 2% alive at 10 years. Erosion of the pterygoids or pterygopalatine fossa invasion as diagnosed radiologically or intra-operatively revealed all patients dead of disease within five years despite radical surgery and irradiation. Cervical nodal metastases at primary presentation was a particularly ominous finding with all patients dead of disease within three years. Metastases developing later had a better prognosis with 39% surviving five years when treated aggressively.
 ...
PMID:Carcinoma of the maxillary sinus. A correlation of the clinical course with orbital involvement, pterygoid erosion or pterygopalatine invasion and cervical metastases. 630 78

This account of 58 spontaneous tumors involving bone in domestic cats compares and contrasts the pathological findings with previous surveys. Of the tumors described, only one was diagnosed as benign. Squamous cell carcinoma was the most common tumor of the series; osteosarcoma was the most common primary tumor. Only two tumors metastasized to the lungs (one hemangiosarcoma and one osteosarcoma), and only three metastasized to a regional node (two squamous cell carcinomas and one lymphosarcoma).
 ...
PMID:Tumors involving bone in the domestic cat: a review of fifty-eight cases. 658 Jul 73

More aggressiveness in treatment of childhood malignancies has had an evident impact on survival and rate of cure but, it has also allowed us to discover long-term effects of these treatments, and second malignant tumors of them. Between 1970 and 1993, 472 cases of malignant tumors in childhood were diagnosed in our department. Six of them (1.27%) developed a second tumor (five malignant and one benign). Relationship between first and second tumors are: seven years old boy, cervical lymphosarcoma-thyroid carcinoma; eleven years old boy, osteogenic sarcoma-vesical carcinoma: two years and six months old boy, cerebellar astrocytoma-soft tissue osteogenic sarcoma; five years old girl. Wilm's tumor-scapular osteogenic chondroma; one year and a half old girl, abdominal neuroblastoma-granulocytic sarcoma (chloroma); twelve years old boy. Hodgkin's disease-acute myeloblastic leukemia. All of them were clearly related to concogenic effect of radiation or chemotherapy.
 ...
PMID:[Second tumors in childhood]. 776 70

The concept of enhancing the normal immune response against infections and neoplasms has been considered for decades. The administration of various natural and synthetic products to simulate systemic infections has largely given over to the idea that specific cytokines can be used effectively when administered systemically. Interferons, interleukins, and hematopoietic growth factors may offer substantial clinical benefit in chronic viral infections, and cancers such as osteosarcoma, melanoma, and lymphosarcoma. Erythropoietin has been shown to have great utility in the management of chronic renal failure. At this point in time, only recombinant products derived from humans are commercially available, and they are expensive and not licensed for use in companion animals. Nevertheless, these products may have significant clinical impact on several highly fatal disorders of dogs and cats. When administered systemically, cytokines perturb complex regulatory pathways, and serious side effects may occur. Innovative delivery methods, such as liposomes, gene therapy, and even oral administration may increase the therapeutic index of these molecules. Biological response modification, cytokine biology, and associated delivery systems are rapidly changing fields, and the small animal veterinarian will need to watch for significant advances in these areas over the next several years.
 ...
PMID:Biological response modifiers: interferons, interleukins, recombinant products, liposomal products. 955 49

Tracheobronchial lymphadenomegaly is commonly associated with lymphosarcoma and disseminated mycotic infection. Available data also suggest other pathologic causes of enlarged tracheobronchial lymph nodes. Our objective was to establish the distribution and prevalence of diseases that cause radiographically evident tracheobronchial lymphadenomegaly in a large population of dogs. Patients were divided into groups based on the methods of diagnoses with 25 having confirmed diagnoses and 85 with presumptive diagnoses. Of the 110 dogs in the study, 92 (84%) had neoplasia and 18 (16%) had infectious diseases. Infections were attributed to Coccidioides (12, 67%), Aspergillus (3, 17%), and 1 each (6%) to Nocardia, Penicillium, and Mycobacteriosis. Tumors were characterized as lymphoma (66, 60%) or nonlymphoid (26, 23.6%). Nonlymphomas in Group 1 included histiocytic sarcoma complex (16%), carcinoma (12%), adenocarcinoma (8%), osteosarcoma (8%), chemodectoma (4%), ganglioneuroblastoma (4%), and neuroendocrine (4%). The number of dogs with tracheobronchial lymphadenomegaly scores 1, 2, 3, 4, or 5 (with 5 being the greatest) was 8 (7%), 15 (14%), 30 (27%), 15 (14%), and 44 (38%), respectively. The results suggest that in addition to diagnoses of lymphoma and fungal infections, other neoplasms and in particular histiocytic sarcoma and metastatic adenocarcinoma, should be considered when tracheobronchial lymphadenomegaly is identified radiographically in dogs. When comparing the degree of tracheobronchial lymphadenopathy by disease category, there was no significant affiliation (P = 0.33).
 ...
PMID:Relationship between radiographic evidence of tracheobronchial lymph node enlargement and definitive or presumptive diagnosis. 2281 44


<< Previous 1 2